Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease
2017 · New England Journal of Medicine · 2,370 citations
https://doi.org/10.1056/nejmoa1709118
M
Masatsugu Hori
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
502
Papers
14.9K
Citations
64
h-index
148
i10-index
Masatsugu Hori is an academic researcher from Osaka International Cancer Institute. The author has contributed to research in topics: Cardiovascular Function and Risk Factors & Cardiac Imaging and Diagnostics & Cardiac Ischemia and Reperfusion. The author has an h-index of 64, co-authored 427 publications.
Papers by this author
worksPrognostic significance of atrial fibrillation/atrial flutter in patients with acute myocardial infarction treated with percutaneous coronary intervention
2003 · The American Journal of Cardiology · 169 citations
https://doi.org/10.1016/j.amjcard.2003.07.021
Efficacy and Safety of Tolvaptan in Heart Failure Patients with Volume Overload Despite the Standard Treatment with Conventional Diuretics: A Phase III, Randomized, Double-blind, Placebo-controlled Study (QUEST Study)
2011 · Cardiovascular Drugs and Therapy · 157 citations
https://doi.org/10.1007/s10557-011-6304-x
[Calcium channel blocker and cardiac hypertrophy].
2005 · PubMed · 2 citations
https://doi.org/
Individual acute-phase bleeding and thrombotic risk balance assessment in patients undergoing percutaneous coronary intervention for acute myocardial infarction
2023 · American Heart Journal Plus Cardiology Research and Practice · 1 citations
https://doi.org/10.1016/j.ahjo.2023.100292
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat